Clinical Trials Logo

Osteoarthritis clinical trials

View clinical trials related to Osteoarthritis.

Filter by:

NCT ID: NCT06377813 Recruiting - Knee Osteoarthritis Clinical Trials

Combined Mode-Kinetic Chain Exercise With and Without Core Stability Exercises on Patients With Knee Osteoarthritis

Start date: November 20, 2023
Phase: N/A
Study type: Interventional

The goal of this [type of study: Randomized control trial] is to [ see the effects of Combined Mode Kinetic Chain Exercises along with or without core stability exercises on pain, range of motion and disability ] in [ in patients with Knee Osteoarthritis].The main question it aims to answer is: Wether core stability exercises is effective if performed along with Combined chain kinetic exercises to improves the condition of Knee Osteoarthritis? Group A will receive Core Stability Exercises along with Combined Chain Kinetic Exercises and Group B will receive combined Chain Kinetic Exercises.

NCT ID: NCT06370312 Not yet recruiting - Clinical trials for Osteoarthritis, Knee

Analysis of Articular Biomarkers From Osteoarthritic Thumb Basal Joints

Start date: May 1, 2024
Phase:
Study type: Observational

The study project aims at examining molecular markers in synovial fluid, bone and articular cartilage from osteoarthritic thumb basal joints. The degradation of extracellular matrix (ECM) proteins in thumb basal joints will be evaluated in association to the metabolic profile of the patient, but we also aim to compare the ECM degradation and inflammatory profiles with articular cartilage degradation ECM profile from knee joints with osteoarthritis. A third aim is to evaluate associations between patient-reported hand function, pain, strength and range of thumb motion to analyses of synovial fluid.

NCT ID: NCT06367283 Not yet recruiting - Hand Osteoarthritis Clinical Trials

Metformin Treatment of Patients With Hand Osteoarthritis

METRO
Start date: June 2024
Phase: Phase 3
Study type: Interventional

To compare metformin (2 g daily), or maximum tolerated dose, for 16 weeks with placebo as a treatment of hand osteoarthritis symptoms.

NCT ID: NCT06363643 Not yet recruiting - Clinical trials for Osteo Arthritis Knee and Hip

Lower Limb Arthroplasty: Effects of a Tele Prehabilitation Program With Indirect Electrostimulation.

Start date: April 22, 2024
Phase: N/A
Study type: Interventional

Preoperative fitness is known to predict postoperative outcomes following lower limb arthroplasty, but many patients, especially the most fragile, arrive at surgery with reduced mobility and functional capacity. Prehabilitation (Prehab) encompasses a series of interventions that are intended to help patients improve their physical state and psychological well-being pre-intervention to reduce the days of hospitalization and the number of post-operative complications. Patients who participate in Prehab require less postoperative care and consequently have less impact on the cost of the healthcare system. However, adherence to a face-to-face program is usually poor and presents both organizational and psychophysical barriers. In the last years, telerehabilitation has proven to be a viable alternative to face-to-face treatment and has already been adopted for the Prehab. Electrostimulation (ESM) is regularly used successfully in clinical settings for the recovery of muscle tone in patients with orthopedic pathologies. In addition, it has already been used for Prehab, showing an increase in muscle strength and a decrease in postoperative hospital stay following knee arthroplasty. Also Exercise offers benefits in the treatment of orthopedic patients because improve: strength, cardiovascular fitness, functional capacities and quality of life. Therefore, in a group of patients who are candidates for elective lower limb arthroplasty surgery, it was decided to evaluate the effects of a Tele Prehab program, based on the ESM, and compare them with those of an Tele Prehab exercise program, equal in dose and duration. The proposal differs from those present in the literature for complete administration in telerehabilitation, including evaluations.

NCT ID: NCT06359301 Recruiting - Hip, Osteoarthritis Clinical Trials

H-34 DELTA Revision Cup

Start date: September 14, 2021
Phase:
Study type: Observational

THis study is aimed to provide a clinical and radiographic evaluation of 49 suitable subjects who underwent a total hip arthroplasty with DELTA Revision acetabular cup.

NCT ID: NCT06359171 Not yet recruiting - Knee Osteoarthritis Clinical Trials

Effectiveness of the ARTH-e Application on Adherence to Physical Exercises in Patients Suffering From KOA: RCT

ARTH-e3
Start date: May 3, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effectiveness of a smartphone-based e-health application (intervention group) compared with standard care (control group) in terms of changes in adherence in patients with knee osteoarthritis using the EARS questionnaire. In addition, other questionnaires presented in the appendix (KOOS, TSK, EPAP, EQ-5D-3L, pain) will be given to all patients in order to meet the secondary evaluation criteria.

NCT ID: NCT06358521 Recruiting - Knee Osteoarthritis Clinical Trials

Determining the Impact of a Physiotherapist-led Primary Care Model for Hip and Knee Pain - A Cluster Trial

Start date: October 2, 2023
Phase: N/A
Study type: Interventional

This is a cluster randomized controlled trial to to evaluate the individual and health system impacts of implementing a new physiotherapist-led primary care model for hip and knee pain in Canada.

NCT ID: NCT06357741 Completed - Knee Osteoarthritis Clinical Trials

Clinical Study of Desuzumab in the Treatment of Knee Osteoarthritis

CSODITTOKO
Start date: March 2, 2023
Phase:
Study type: Observational

As an activator of inhibiting nuclear factor kB receptor, denosumab affects osteoclast differentiation and development by inhibiting OPG/RANKL-RANK bone regulatory axis pathway. Therefore, denosumab is widely used in the treatment of bone diseases such as osteoporosis. Osteoporosis is closely related to knee osteoarthritis. RANKL-RANK pathway also plays a key role in the pathogenesis of knee osteoarthritis. Therefore, the investigators propose the hypothesis that denosumab can effectively treat knee osteoarthritis.

NCT ID: NCT06354023 Not yet recruiting - Clinical trials for Osteoarthritis, Knee

Human Growth Hormone Injections in the Knee Joint to Treat Osteoarthritis

Start date: May 8, 2024
Phase: Phase 2
Study type: Interventional

The goal of this clinical trial is to learn if growth hormone injections can be used to treat osteoarthritis (OA) in the knee. Human studies have shown that repeated injections of human growth hormone leads to the production of articular chondrocytes, which are the cells that make up the cartilage in the knee joint. Restoring cartilage in the knee can alleviate pain, improve function, and postpone the need for a joint replacement procedure. The main questions the study aims to answer are: - Do growth hormone injections in the knee joint stimulate cartilage growth? - Do the injections lower pain and stiffness in the participant's treated knee? - Does the participant have more mobility after the injections? The physician will monitor the participant's progress through X-ray images, questionnaires, and physical evaluation of the treated knee. For the trial, participants will: - Receive a growth hormone injection in their knee once per week for six weeks, for a total of 6 injections. - Complete at-home exercises during the treatment period. - Use crutches as needed during the trial. - Have X-rays taken at 8 weeks, 6 months, and 12 months after the first injection. - Go to follow-up visits at 8 weeks, 6 months, and 12 months after the first injection. - Complete treatment surveys before treatment starts and after it is finished.

NCT ID: NCT06351059 Active, not recruiting - Clinical trials for Osteoarthritis, Knee

Acoustic Emission Biomarkers for the Detection and Monitoring of Early Knee Osteoarthritis

Start date: January 1, 2023
Phase:
Study type: Observational

The aim of this exploratory study is to further investigate the potential of acoustic emission biomarkers, assessed by the inmodi knee brace, to diagnose osteoarthritis (OA) at earlier stages. Therefore, 20 healthy participants and 100 patients with increased risk of knee OA will be recruited from the Schulthess Klinik in Zurich and examined twice with 9 ± 3 months' time interval. Anthropometric data, EOS radiographs and MR images of both knees, PROMs and acoustic emission data will be collected and evaluated. Artificial Intelligence algorithm will then be used to identify and validate the most promising acoustic emission biomarkers with a prognosis value in the prediction of knee osteoarthritis progress.